MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/rheumatology/keae189

Медицинская библиотека · Rheumatology (Oxford, England) · 2025

Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.

Carlucci Philip M, Preisinger Katherine, Deonaraine Kristina K, Zaminski Devyn, Dall'Era Maria, Gold Heather T, Kalunian Kenneth, Fava Andrea, Belmont H Michael, Wu Ming, Putterman Chaim, Anolik Jennifer, Barnas Jennifer L, Furie Richard, Diamond Betty, Davidson Anne, Wofsy David, Kamen Diane, James Judith A, Guthridge Joel M, Apruzzese William, Rao Deepak, Weisman Michael H, Izmirly Peter M, Buyon Jill, Petri Michelle, Accelerating Medicines Partnership in RA/SLE Network

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

OBJECTIVE

Lupus nephritis (LN) can occur as an isolated component of disease activity or be accompanied by diverse extrarenal manifestations. Whether isolated renal disease is sufficient to decrease health-related quality of life (HRQOL) remains unknown. This study compared Patient-Reported Outcomes Measurement Information System 29-Item (PROMIS-29) scores in LN patients with isolated renal disease to those with extrarenal symptoms to evaluate the burden of LN on HRQOL and inform future LN clinical trials incorporating HRQOL outcomes.

METHODS

A total of 181 LN patients consecutively enrolled in the multicentre multi-ethnic/racial Accelerating Medicines Partnership completed PROMIS-29 questionnaires at the time of a clinically indicated renal biopsy. Raw PROMIS-29 scores were converted to standardized T scores.

RESULTS

Seventy-five (41%) patients had extrarenal disease (mean age 34, 85% female) and 106 (59%) had isolated renal (mean age 36, 82% female). Rash (45%), arthritis (40%) and alopecia (40%) were the most common extrarenal manifestations. Compared with isolated renal, patients with extrarenal disease reported significantly worse pain interference, ability to participate in social roles, physical function, and fatigue. Patients with extrarenal disease had PROMIS-29 scores that significantly differed from the general population by >0.5 SD of the reference mean in pain interference, physical function, and fatigue. Arthritis was most strongly associated with worse scores in these three domains.

CONCLUSION

Most patients had isolated renal disease and extrarenal manifestations associated with worse HRQOL. These data highlight the importance of comprehensive disease management strategies that address both renal and extrarenal manifestations to improve overall patient outcomes.

Для цитирования: Carlucci Philip M, Preisinger Katherine, Deonaraine Kristina K, Zaminski Devyn, Dall'Era Maria, Gold Heather T, Kalunian Kenneth, Fava Andrea, Belmont H Michael, Wu Ming, Putterman Chaim, Anolik Jennifer, Barnas Jennifer L, Furie Richard, Diamond Betty, Davidson Anne, Wofsy David, Kamen Diane, James Judith A, Guthridge Joel M, Apruzzese William, Rao Deepak, Weisman Michael H, Izmirly Peter M, Buyon Jill, Petri Michelle, Accelerating Medicines Partnership in RA/SLE Network. Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.. Rheumatology (Oxford, England). 2025. DOI: 10.1093/rheumatology/keae189.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.